SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics $CAPR is trending due to anticipation surrounding the release of pivotal Phase 3 HOPE-3 study data for Duchenne Muscular Dystrophy. The community is buzzing with speculation about the results and potential for a short squeeze, while also debating the validity of past criticism from prominent short sellers. Some traders are setting very high price targets based on the potential for FDA approval and buyout prospects.

$SMOL is the first memecoin with a verified OnlyFans launched on Solana via pump.fun. It follows Smol, a rescued Alabama dachshund who survived hoarding, shelter hunger, and a 5-day post-spay escape before finding her forever home. Now pampered with treats and spa days, she shares wholesome content—no adult themes, just derpy faces, snack videos, and rescue love. $SMOL aims to normalize kindness and support animal welfare through the creator economy.

Smol Fans

$SMOL is trending as community members rally around its unique narrative: a rescue dog on OnlyFans supporting other rescue animals. With comparisons to early-stage $DOGE and a focus on community-driven growth, $SMOL is gaining attention as a potential leader in the memecoin space on the Solana network. The coin's organic growth and the team's dedication are key talking points driving interest.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsoft is trending due to reports of lowered AI software sales quotas, sparking concerns about AI leadership and competition from Google. The community is debating the impact on MSFT's AI strategy and its broader influence on the market, especially in relation to AI hardware players like NVDA. Some investors view this as a buying opportunity, while others express disappointment and question the company's current direction.

Marvell Technology, Inc. engages in the design, development, and sale of integrated circuits. Its products include data processing units, security solutions, automotive, coherent DSP, DCI optical modules, ethernet controllers, ethernet PHYs, ethernet switches, linear driver, PAM DSP, transimpedance amplifiers, fibre channel, HDD, SSD controller, storage accelerators, ASIC, and Marvell government solutions. It operates through the following geographical segments: United States, Singapore, Israel, India, China, and Others. The company was founded by Wei Li Dai and Pantas Sutardja in 1995 and is headquartered in Wilmington, DE.

Marvell Technology Inc

Marvell Technology is trending following a positive upgrade driven by anticipated data-center growth and its acquisition of Celestial AI, which is viewed as a strategic move into AI interconnectivity. The community is weighing whether to chase the breakout or await a potential pullback, while analysts are raising price targets. Upgrades and catalysts are aligning after earnings, with many feeling it's a good entry point.

Serve Robotics, Inc. engages in providing self-driving delivery. It designs, develops, and operates zero-emissions robots that serve people in public spaces, starting with food delivery. The company was founded by Ali Kashani, Dmitry Demeshchuk and MJ Burk Chun in 2017 and is headquartered in Redwood City, CA.

Serve Robotics Inc

Serve Robotics is trending as the community discusses its potential following a recent partnership, speculating on future revenue growth and potential acquisitions. Despite some short-term price fluctuations, investors are focused on the company's long-term prospects in the growing robotics and autonomous delivery sector, with some eyeing specific price targets. Chatter also revolves around potential government investment and expansion into new cities.

Ondas Holdings, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in Boston, MA.

Ondas Holdings Inc

Ondas Holdings is trending due to a major government contract win for an autonomous border-protection drone system, sparking significant community excitement. Investors are actively discussing the potential impact of this contract on future growth, the company's position in the defense sector, and possible short squeezes. The contract news has reinforced optimism about Ondas's long-term prospects.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IREN is trending downwards as investors react to news of a large share offering intended to fund the repurchase of convertible notes, with some fearing dilution. The community is debating the long-term implications of this financial move, with opinions divided on whether it's a strategic maneuver or a sign of balance sheet strain. Adding to the volatility, commentary from Jim Cramer on CNBC has further fueled debate and speculation around the stock's future.

CrowdStrike Holdings, Inc. provides cybersecurity products and services to stop breaches. It offers cloud-delivered protection across endpoints, cloud workloads, identity and data, and threat intelligence, managed security services, IT operations management, threat hunting, Zero Trust identity protection, and log management. CrowdStrike serves customers worldwide. The company was founded by George P. Kurtz, Gregg Marston, and Dmitri Alperovitch on November 7, 2011 and is headquartered in Austin, TX.

Crowdstrike Holdings Inc - Ordinary Shares - Class A

Crowdstrike Holdings Inc

CRWD is trending following analyst upgrades and price target increases after a strong quarter, with focus on ARR re-acceleration and successful scaling of its Flex licensing model. Community members are actively discussing the stock's steady buyer resilience and potential longer cycle strength, while also acknowledging the high expectations and potential for volatility. The cybersecurity sector's strength is also contributing to the positive sentiment.

Clene, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology therapeutics. It offers a nanotechnology drug platform for the development of a new class of orally administered neurotherapeutic drugs. The company was founded in 2013 and is headquartered in Salt Lake City, UT.

Clene Inc

Clene Inc. ($CLNN) is trending due to positive ALS biomarker data for their drug candidate CNM-Au8, reigniting community excitement around a potential accelerated approval filing with the FDA. Discussions revolve around whether the data package meets the FDA's criteria, with many highlighting statistically significant NfL reductions and biomarker concordance. Community members are closely watching for further company announcements and potential implications for ALS patients.

Ripple is the catchall name for the cryptocurrency platform, the transactional protocol for which is actually XRP, in the same fashion as Ethereum is the name for the platform that facilitates trades in Ether. Like other cryptocurrencies, Ripple is built atop the idea of a distributed ledger network which requires various parties to participate in validating transactions, rather than any singular centralized authority. That facilitates transactions all over the world, and transfer fees are far cheaper than the likes of bitcoin. Unlike other cryptocurrencies, XRP transfers are effectively immediate, requiring no typical confirmation time.  Ripple was originally founded by a single company, Ripple Labs, and continues to be backed by it, rather than the larger network of developers that continue bitcoin’s development. It also doesn’t have a fluctuating amount of its currency in existence. Where bitcoin has a continually growing pool with an eventual maximum, and Ethereum theoretically has no limit, Ripple was created with all of its 100 billion XRP tokens right out of the gate. That number is maintained with no mining and most of the tokens are owned and held by Ripple Labs itself — around 60 billion at the latest count.  Even at the recently reduced value of around half a dollar per XRP, that means Ripple Labs is currently sitting on around $20 billion worth of the cryptocurrency (note: Ripple’s price crashed hard recently, and may be worth far less than $60 billion by time you read this). It holds 55 billion XRP in an escrow account, which allows it to sell up to a billion per month if it so chooses in order to fund new projects and acquisitions. Selling such an amount would likely have a drastic effect on the cryptocurrency’s value, and isn’t something Ripple Labs plans to do anytime soon.  In actuality, Ripple Labs is looking to leverage the technology behind XRP to allow for faster banking transactions around the world. While Bitcoin and other cryptocurrencies are built on the idea of separating financial transactions from the financial organizations of traditional currencies, Ripple is almost the opposite in every sense.  XRP by Ripple price can be found on this page alongside the market capitalization and additional stats.

Ripple

XRP is trending as discussions center on its potential utility amid news of increasing institutional interest and ETF inflows outpacing those of BTC and ETH. The community is weighing the significance of recent developments, including staking options and potential integration into global payment systems. Broader market factors and regulatory developments are also influencing the conversation around XRP's future.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Neurocrine Biosciences, Inc. $NBIX Shares Sold by Virtus Advisers LLC

Virtus Advisers LLC cut its position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX - Free Report) by 74.8% during the second quarter, according to its most recent Form 13F filing with the SEC. The...

Loomis Sayles & Co. L P Acquires New Position in Neurocrine Biosciences, Inc. $NBIX

Loomis Sayles & Co. L P bought a new position in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX - Free Report) during the 2nd quarter, according to the company in its most recent 13F filing with...

Distillate Capital Partners LLC Sells 8,175 Shares of Neurocrine Biosciences, Inc. $NBIX

Distillate Capital Partners LLC lessened its position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX - Free Report) by 6.3% in the second quarter, according to the company in its most recent filing...

Edgestream Partners L.P. Takes $9.25 Million Position in Neurocrine Biosciences, Inc. $NBIX

Edgestream Partners L.P. purchased a new stake in Neurocrine Biosciences, Inc. (NASDAQ:NBIX - Free Report) in the 2nd quarter, according to the company in its most recent filing with the SEC. The...

Skandinaviska Enskilda Banken AB publ Reduces Holdings in Neurocrine Biosciences, Inc. $NBIX

Skandinaviska Enskilda Banken AB publ reduced its position in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX - Free Report) by 49.3% during the second quarter, according to the company in its...

Quadrature Capital Ltd Purchases 11,162 Shares of Neurocrine Biosciences, Inc. $NBIX

Quadrature Capital Ltd increased its position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX - Free Report) by 306.1% in the second quarter, according to the company in its most recent filing with the...

Capital Fund Management S.A. Grows Holdings in Neurocrine Biosciences, Inc. $NBIX

Capital Fund Management S.A. lifted its position in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX - Free Report) by 15.9% during the 2nd quarter, according to the company in its most recent 13F...

Prudential Financial Inc. Purchases 26,030 Shares of Neurocrine Biosciences, Inc. $NBIX

Prudential Financial Inc. increased its position in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX - Free Report) by 21.8% during the 2nd quarter, according to its most recent filing with the...

Creative Planning Raises Position in Neurocrine Biosciences, Inc. $NBIX

Creative Planning lifted its stake in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX - Free Report) by 31.6% during the 2nd quarter, according to the company in its most recent 13F filing with...

Insider Selling: Neurocrine Biosciences (NASDAQ:NBIX) Director Sells 15,000 Shares of Stock

Neurocrine Biosciences, Inc. (NASDAQ:NBIX - Get Free Report) Director George Morrow sold 15,000 shares of the business's stock in a transaction that occurred on Tuesday, November 25th. The stock was...

Neurocrine Biosciences, Inc. is a neuroscience-focused, biopharmaceutical company, which engages in the research and development, commercialization, and sale of pharmaceuticals for the treatment of neurological, neuroendocrine, and neuropsychiatric disorders. Its portfolio of products includes treatments for tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia (CAH), and endometriosis and uterine fibroids. The company was founded by Kevin C. Gorman and Wylie W. Vale in January 1992 and is headquartered in San Diego, CA.

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	$1.86	--	--	N/A
Q3 '25	$1.59	$2.04	28.53%	BEAT
Q2 '25	$0.96	$1.06	9.89%	BEAT
Q1 '25	$0.54	$0.08	-85.05%	MISSED
Q4 '24	$1.58	$1.00	-36.78%	MISSED

NBIX
Neurocrine Biosciences, Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q4 '25

Historical Earnings

Latest NBIX News

NBIXNeurocrine Biosciences, Inc.